Safety and long-term effectiveness of teduglutide in children with intestinal failure due to short bowel syndrome: a multicenter, post-marketing cohort study.
In children treated with teduglutide, a progressive and sustained reduction in parenteral support up to 3 years is found and careful monitoring of nutritional status while on this new medication is warranted.